Help | RSS Feed

PDL BioPharma Inc. (NASD:PDLI) Seasonal Chart

PDL BioPharma Inc. (NASD:PDLI) Seasonality

PDLI Relative to the S&P 500
PDLI Relative to the S&P 500

PDLI Relative to the Sector
PDLI Relative to the Sector

Monthly Seasonal PDL BioPharma Inc. (NASD:PDLI)

Seasonal Chart Analysis

Analysis of the PDL BioPharma Inc. (NASD:PDLI) seasonal charts above shows that a Buy Date of March 26 and a Sell Date of August 4 has resulted in a geometric average return of 8.87% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 16 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 15.35% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

PDL BioPharma Inc is engaged in the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing value of its patent.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore